A phase II trial of the mTOR inhibitor AP23573 as a single agent in advanced endometrial cancer Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Colombo, N., McMeekin, S., Schwartz, P., Kostka, J., Sessa, C., Gehrig, P., Holloway, R., Braly, P., Matei, D., Einstein, M.

Publication Date

  • June 20, 2007

webpage

published in

category

volume

  • 25

issue

  • 18

WoS Citations

  • 163

WoS References

  • 0